id: alcohol_use_disorder_diagnosis_to_daa_hcv_treatment_receipt
name: Alcohol Use Disorder Diagnosis â†’ Direct-Acting Antiviral HCV Treatment Receipt
from_node:
  node_id: alcohol_use_disorder_diagnosis
  node_name: Alcohol Use Disorder Diagnosis
to_node:
  node_id: daa_hcv_treatment_receipt
  node_name: Direct-Acting Antiviral HCV Treatment Receipt
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Patients with alcohol use disorder diagnosis face stigma and discrimination
  in healthcare settings'
- 'Step 2: Healthcare providers may withhold or delay HCV treatment referrals based
  on misconceptions about alcohol use and treatment eligibility'
- 'Step 3: Structural barriers in healthcare systems (e.g., insurance requirements,
  provider gatekeeping) disproportionately affect patients with substance use disorder
  diagnoses'
- 'Step 4: Patients with alcohol use disorder encounter reduced access to DAA treatment
  despite clinical guidelines recommending treatment regardless of alcohol use'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Lamia Y. Haque et al. 2022. "Association Between Alcohol Use Disorder
    and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment." *JAMA Network
    Open*. https://doi.org/10.1001/jamanetworkopen.2022.46604
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.366830'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: abstinence_status
  direction: weakens
  strength: weak
  description: Even patients with alcohol use disorder who are abstinent experience
    barriers to treatment, suggesting that current alcohol use is not the primary
    mechanism but rather the diagnosis itself creates barriers
- name: demographic_characteristics
  direction: weakens
  strength: moderate
  description: Association persists after adjusting for demographic characteristics,
    indicating structural barriers beyond individual-level factors
- name: comorbidities
  direction: weakens
  strength: moderate
  description: Association persists after adjusting for comorbidities, suggesting
    barriers are specific to substance use disorder stigma rather than general medical
    complexity
